
    
      PRIMARY OBJECTIVES:

      I. Efficacy for reducing the severity of sexual distress, difficulty, and dysfunction in a
      phase II randomized clinical trial (RCT).

      OUTLINE: Patients are randomized to 1 of 2 arms.

      ARM I (Enhanced standard care): Patients participate in enhanced standard care intervention
      comprising stress reduction, information delivery regarding gynecologic or breast cancer
      treatments and sexuality, and provision of a survivorship care plan (SCP) created using
      OncoLink over 1 hour following baseline assessment and before 6 months.

      ARM II (Psychological intervention): Patients participate in individual or group therapy over
      1.5 hours weekly for 4 weeks, bi-weekly for 8 weeks, and monthly for 2 months and complete
      assessment interviews.

      After completion of study treatment, patients are followed up at 3, 6, and 9 months.
    
  